| 1.7 -0.03 (-1.73%) | 05-03 16:00 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |   |
|||
| Targets | 6-month : | 4.86 | 1-year : | 6.87 |
| Resists | First : | 4.16 | Second : | 5.88 |
| Pivot price | 3.29  |
|||
| Supports | First : | 1.37 | Second : | 1.14 |
| MAs | MA(5) : | 1.63 |
MA(20) : | 3.67 |
| MA(100) : | 3.4 |
MA(250) : | 4.31 |
|
| MACD | MACD : | -0.7 |
Signal : | -0.4 |
| %K %D | K(14,3) : | 7.8 |
D(3) : | 6.1 |
| RSI | RSI(14): 24.3 |
|||
| 52-week | High : | 8.39 | Low : | 1.37 |
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.[ CLVR ] has closed above bottom band by 16.7%. Bollinger Bands are 219.1% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 4 days. This is a sign that the current trend might continue.
| If tomorrow: | Open lower | Open higher |
| High: | 1.79 - 1.8 | 1.8 - 1.81 |
| Low: | 1.62 - 1.63 | 1.63 - 1.65 |
| Close: | 1.68 - 1.7 | 1.7 - 1.72 |
Clever Leaves Holdings Inc. operates as a cannabis company. The company operates through two segments, Cannabinoid and Non-Cannabinoid. The Cannabinoid segment engages in the cultivation, extraction, manufacturing, commercialization, and distribution of cannabinoid products internationally. The Non-Cannabinoid segment is engaged in formulating, manufacturing, marketing, selling, distributing, and commercializing nutraceutical and other natural remedies, wellness products, detoxification products, and nutritional and dietary supplements for mass retailers, specialty and health retailers, and distributors in the United States. The company was founded in 2017 and is based in Boca Raton, Florida.
Fri, 03 May 2024
Bearish: Analysts Just Cut Their Clever Leaves Holdings Inc. (NASDAQ:CLVR) Revenue and EPS estimates - Yahoo Movies Canada
Tue, 30 Apr 2024
Clever Leaves Cannabis Company Exits NASDAQ Amid Financial Strains, Stock Plunges -60%, Investors Impacted ... - Benzinga
Tue, 30 Apr 2024
Why Clever Leaves (CLVR) Stock Is Down 60% - MSN
Mon, 29 Apr 2024
Clever Leaves plunges 60%, plans Nasdaq exit - Green Market Report
Fri, 26 Apr 2024
Clever Leaves Announces Voluntary Delisting and SEC Deregistration - GlobeNewswire
Wed, 17 Apr 2024
Clever Leaves Ends Equity Sales Agreement with Canaccord Genuity - TipRanks.com - TipRanks
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Underperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Drug Manufacturers - Specialty & Generic
|
|
| Shares Out | 2 (M) |
| Shares Float | 2 (M) |
| Held by Insiders | 12.3 (%) |
| Held by Institutions | 7.3 (%) |
| Shares Short | 20 (K) |
| Shares Short P.Month | 17 (K) |
| EPS | -12.64 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 14.02 |
| Profit Margin | -102.8 % |
| Operating Margin | -106 % |
| Return on Assets (ttm) | -23.4 % |
| Return on Equity (ttm) | -61.3 % |
| Qtrly Rev. Growth | 5.4 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | 9.95 |
| EBITDA (p.s.) | -7.56 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | -12 (M) |
| Levered Free Cash Flow | -2 (M) |
| PE Ratio | -0.14 |
| PEG Ratio | 0 |
| Price to Book value | 0.12 |
| Price to Sales | 0.17 |
| Price to Cash Flow | -0.26 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|